These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A circulating lupus-like coagulation inhibitor induced by chlorpromazine. Tollefson G; Rodysill K; Cusulos M J Clin Psychopharmacol; 1984 Feb; 4(1):49-51. PubMed ID: 6420448 [TBL] [Abstract][Full Text] [Related]
3. Plasmapheresis for a schizophrenic patient with drug-induced lupus anti-coagulant. Matsukawa Y; Satoh M; Itoh T; Nishinarita S; Horie T; Abe K; Takahashi A; Kojima T J Int Med Res; 1996; 24(1):147-50. PubMed ID: 8674793 [TBL] [Abstract][Full Text] [Related]
7. Surgical experience on patients with serum lupus anticoagulants. A report of two cases. Minezaki T; Ichikawa Y Tokai J Exp Clin Med; 1993 Dec; 18(3-6):95-7. PubMed ID: 7701535 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants. Devreese KM Thromb Res; 2008; 123(2):404-11. PubMed ID: 18495217 [No Abstract] [Full Text] [Related]
9. Prolonged activated partial thromboplastin times and detection of the lupus anticoagulant. Lucas FV; Miller ML Arch Pathol Lab Med; 1993 Jun; 117(6):589-90. PubMed ID: 8503727 [No Abstract] [Full Text] [Related]
10. The laboratory heterogeneity of lupus anticoagulants. Triplett DA; Brandt JT; Maas RL Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747 [TBL] [Abstract][Full Text] [Related]
11. Lupus anticoagulant testing: effect of the platelet count on the activated partial thromboplastin time. Brien WF; Schaus MR; Cooper KE; O'Keefe BT; Inwood M Br J Biomed Sci; 1993 Jun; 50(2):114-6. PubMed ID: 8219916 [TBL] [Abstract][Full Text] [Related]
12. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol; 1991 Nov; 44(11):885-9. PubMed ID: 1752976 [No Abstract] [Full Text] [Related]
13. A chlorpromazine-induced inhibitor of blood coagulation. Canoso RT; Hutton RA; Deykin D Am J Hematol; 1977; 2(2):183-91. PubMed ID: 888826 [TBL] [Abstract][Full Text] [Related]
15. The automated modified Russell viper venom time test for the lupus anticoagulant. Petri M; Nelson L; Weimer F; Anderson D; Darlington T; Corash L J Rheumatol; 1991 Dec; 18(12):1823-5. PubMed ID: 1795319 [TBL] [Abstract][Full Text] [Related]
16. Effect of instruments on lupus anticoagulant testing. Exner T; Hohnen-Behrens C; Newman P; Dargan W Thromb Haemost; 2000 Feb; 83(2):345-8. PubMed ID: 10739397 [No Abstract] [Full Text] [Related]
17. Fatal bleeding in a patient with a non-specific PT and APTT inhibitor. Krikler SH; Carter CJ; Chonn A; Levitt D; Devine DV Clin Lab Haematol; 1992; 14(1):73-9. PubMed ID: 1600696 [No Abstract] [Full Text] [Related]
18. Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin. Rauch J; Tannenbaum M; Neville C; Fortin PR Thromb Haemost; 1998 Dec; 80(6):936-41. PubMed ID: 9869164 [TBL] [Abstract][Full Text] [Related]
19. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism. Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313 [TBL] [Abstract][Full Text] [Related]
20. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma. Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]